Compare Galaxy Digital Inc. Class A Common Stock (GLXY) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Galaxy Digital Inc. Class A Common Stock vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Galaxy Digital Inc. Class A Common Stock trades at $20.44 (market cap $3.90B), while Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.74B). The key difference: Galaxy Digital Inc. Class A Common Stock is far larger — about 2.2× Nuvation Bio Inc. Class A Common Stock's market cap, and Nuvation Bio Inc. Class A Common Stock is trading nearer its 52-week high, Galaxy Digital Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Galaxy Digital Inc. Class A Common Stock for 0 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.
| GLXY | NUVB | |
|---|---|---|
Market Cap | $3.90B | $1.74B |
Volume | 7,887,173 | 9,289,619 |
Sector | Financials | Health |
52-Week High | $42.86 | $9.54 |
52-Week Low | $16.84 | $3.41 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $6.36B | $1.33B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Galaxy Digital Inc. Class A Common Stock
Galaxy provides digital-asset financial services and data center infrastructure. Its digital-assets business includes trading, asset management, investment banking, staking, tokenization, and custody technology.
Read more on GLXY →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
